No Data
No Data
FibroBiologics Price Target Maintained With a $16.00/Share by D. Boral Capital
FibroBiologics Is Maintained at Buy by D. Boral Capital
H.C. Wainwright Maintains FibroBiologics(FBLG.US) With Buy Rating, Maintains Target Price $12
Express News | HC Wainwright & Co. Reiterates Buy on FibroBiologics, Maintains $12 Price Target
$FBLG Stock Is up 15% Today. Here's What We See in Our Data.
12 Health Care Stocks Moving In Friday's Pre-Market Session
iluvpoptarts : ty much. I owe you a good joke when you're ready
manukahoney : when will CCTG pump occur? pre market today?
Jaguar8 OP manukahoney : it already started pumping Friday AH
manukahoney Jaguar8 OP : is it too late if i pump today during pre market sir?
Arrayfunction : This is probably an unknowable question - but logically, the massive cuts at NIH and NSF are going to stall out the biotech industry with what.....an 8-10 year lag? I know they don't tend to fund private clinical trials all that often, but they are shutting the tap off at the academic institutions that come up with the molecules that biotech/pharma buys the rights to?